J
Julie M. Vose
Researcher at University of Nebraska Medical Center
Publications - 569
Citations - 51589
Julie M. Vose is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Transplantation & Lymphoma. The author has an hindex of 97, co-authored 541 publications receiving 46915 citations. Previous affiliations of Julie M. Vose include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era
Andrew M. Evens,Jennifer A. Kanakry,Laurie H. Sehn,Tatyana Feldman,Aimee Kroll,Randy D. Gascoyne,Adam M. Petrich,Jeremy S. Abramson,Francisco J. Hernandez-Ilizaliturri,Zeina Al-Mansour,Camille Adeimy,Jessica Hemminger,Nancy L. Bartlett,Anthony R. Mato,Paolo Caimi,Ranjana H. Advani,Andreas K. Klein,Izidore S. Lossos,Oliver W. Press,Jonathan W. Friedberg,Julie M. Vose,Kristie A. Blum +21 more
TL;DR: A multicenter retrospective analysis of newly diagnosed GZL patients treated from 2001-2012 at 18 North American academic centers determined prognostic factors associated with survival on univariate and multivariate Cox regression analyses and found that despite having lower risk features, the PFS or OS for MGZL is not superior.
Journal ArticleDOI
Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)
Bruce D. Cheson,Nancy L. Bartlett,Julie M. Vose,A. Lopez-Hernandez,A. L. Seiz,Anne Keating,S. Shamsili,K. P. Papadopoulos,Kyriakos P. Papadopoulos +8 more
Journal ArticleDOI
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A. Riedell,Mehdi Hamadani,Kwang Woo Ahn,Carlos Litovich,Claudio G. Brunstein,Amanda F. Cashen,Jonathon B. Cohen,Narendranath Epperla,Brian T. Hill,Annie Im,David J. Inwards,John Lister,John M. McCarty,Sai Ravi Pingali,Mazyar Shadman,Mazyar Shadman,Paul Shaughnessy,Melhem Solh,Patrick J. Stiff,Julie M. Vose,Mohamed A. Kharfan-Dabaja,Alex F. Herrera,Craig S. Sauter,Craig S. Sauter,Sonali M. Smith +24 more
TL;DR: In this article, the authors evaluated the effect of post-autoHCT time to relapse on overall survival (OS) over time in 461 patients who underwent up-front autoHCT within 12 months of mantle cell lymphoma diagnosis.
Journal ArticleDOI
Tositumomab and Iodine I 131 Tositumomab (the BEXXAR® Therapeutic Regimen) Shows Efficacy in Elderly Patients (pts) with Relapsed/Refractory Low-Grade (LG), Follicular, and Transformed Non-Hodgkin’s Lymphoma (NHL).
Stephanie A. Gregory,Andrew D. Zelenetz,Susan J. Knox,Julie M. Vose,John P. Leonard,Mark S. Kaminski +5 more
TL;DR: BEXXAR can be administered safely and effectively to older pts with low-grade follicular or transformed NHL treated with BexXAR, and response rates and durations of response are somewhat better in younger pts than in older pts, but pts >60 yrs presented with poorer prognostic features.
Journal ArticleDOI
Phase i/ii study of choep plus lenalidomide as initial therapy for patients with stage ii-iv peripheral t-cell lymphoma: phase ii results
Matthew A. Lunning,Steve Horwitz,R. Advani,Julie M. Vose,Hun J. Lee,Neha Mehta-Shah,Jasmine Zain,Brad Haverkos,Mary Jo Lechowicz,A.J. Moskowitz,Peggy Heires,L. Lyden,S. M. Ansell +12 more
TL;DR: University Third Hospital, Beijing, China; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China'; department of Hem atology, Peking University First hospital, Beijing; andDepartment of HemAtology, Beijing Tongren Hospital.